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Introduction {#sec1}
============

Enterovirus A71 (EV-A71), a typical positive single-stranded RNA virus, was first identified in 1969 in patients with central nervous system disease ([@bib22], [@bib28]). EV-A71 belongs to the Picornaviridae family of viruses, with a genome of nearly 7.4 kb encoding four structural proteins (VP1, VP2, VP3, and VP4) and seven non-structural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D) ([@bib16], [@bib21]). EV-A71 has also been recognized as an agent for hand-foot-and-mouth disease (HFMD). HFMD is usually a mild and self-limiting disease; however, sometimes it causes severe neurological disorders or even death due to the limited effective treatment for EV-A71 infection ([@bib10], [@bib38]). Furthermore, EV-A71 has shown repeated outbreaks worldwide in the last decade and infects millions of people annually ([@bib38]).

It is well known that the initiation of EV-A71 protein translation the first step for initiating viral replication after entry into host cells is driven by the internal ribosome entry site (IRES) in the 5′ UTR. This occurs in a cap-independent manner and is regulated by many positive and negative regulators ([@bib14]). EV-A71 contains a type I IRES with five stem loops (domains II--VI), which binds to the cleaved eukaryotic initiation factor eIF4G ([@bib33]). The viral translation process is highly promoted by viral protein 2A protease (2A^pro^). The protein 2A^pro^ cleaves eIF4G, and then the cleaved eIF4G binds and enhances viral IRES activity ([@bib8]). Although a number of IRES *trans*-acting factors (ITAFs), such as AU-rich element-binding factor 1 (AUF1) ([@bib17]), upstream element-binding protein (FBP) 1--3 ([@bib12]), hnRNP K ([@bib18]), and hnRNP A1 ([@bib19]) have been identified, current knowledge on their regulation is very limited.

Previous studies have uncovered several host factors required for EV-A71 replication. For example, the virus first attaches to the cell membrane factors heparan sulfate glycosaminoglycans ([@bib32]) and PSGL1 ([@bib24]). It then releases the viral genome for the production of viral components helped by host factors such as AUF1 ([@bib17]), FBP1 ([@bib12]), and hnRNP A1 ([@bib19]) and is subsequently assembled for the release of the virus from cells. It has been shown that some pan protein kinases, such as phosphatidylinositol 3-kinase and MERK/ERK kinases, play crucial roles in EV-A71 replication ([@bib6], [@bib13], [@bib35], [@bib40]). The inhibitors of these kinases potently inhibited viral replication ([@bib31], [@bib39]). However, results from anticancer clinical studies of these inhibitors showed strong side effects. It would be a great idea to target a specific kinase to treat cancers and viral infections.

Pim1, a member of the calmodulin-dependent protein kinase family together with another two kinases, is a serine-threonine kinase identified as the preferential site of integration for the Moloney murine leukemia virus ([@bib29]). Pim1 is elevated and plays crucial roles in several types of human cancers such as prostate adenocarcinoma, mantle cell lymphomas, and hematopoietic malignancies ([@bib23]). Recently, several groups reported that Pim1 affects viral transcription activation and modulates the latency and productive infections ([@bib4], [@bib26], [@bib34]). However, to date there have been no reports that show any response or effect of Pim1 in EV-A71 replication. Therefore, in this study, we analyzed the expression profile of Pim1 after EV-A71 infection. We showed that Pim1 was upregulated in response to EV-A71 infection. More importantly, we not only demonstrated the importance of Pim1 in EV-A71 infection but also revealed the potent antiviral effects of Pim1 inhibitors, potential agents for antiviral treatment as well.

Results {#sec2}
=======

Stimulation of Pim1 mRNA Level by EV-A71 Infection {#sec2.1}
--------------------------------------------------

To reveal the regulation pattern of Pim1 in EV-A71 infection, the mRNA level of Pim1 was analyzed during the process of viral infection. RD cells were infected with EV-A71 or inactive EV-A71 (UV light-inactive virus) at MOI of 1 and 10, and cellular mRNA was extracted at different time points (post infection, p.i.). The results showed that the mRNA level of Pim1 notably increased as early as 3 h p.i. at a high MOI of 10, and significant upregulation was observed at 6 and 9 h p.i. both at MOIs 1 and 10, when compared with the control group ([Figure 1](#fig1){ref-type="fig"}A). Notably, although virus treated with UV would not affect virus entry ([@bib5], [@bib3]), it did not stimulate Pim1 response.Figure 1Inhibiting EV-A71 Replication by Knockdown of Pim1(A) RD cells were infected with EV-A71 or inactive EV-A71 (UV light-inactive virus, negative control) at MOI of 10, and cellular mRNA was extracted at different time points p.i. Pim1 mRNA level was determined by qRT-PCR.(B and D) Pim1 was silenced by two individual siRNA duplexes si-Pim1-1 and si-Pim1-2. The relative cellular Pim1 mRNA level was quantified by qRT-PCR at 48 h after transfection in both (B) RD and (D) HeLa cells. GAPDH was used as the internal control.(C and E) (C) RD and (E) HeLa cells treated with Pim1-specific siRNA and infected with EV-A71 at MOI 0.01. The extracellular viral RNA level was calculated at 48 h.(F and G) Viral titer was further determined in both (F) RD and (G) HeLa cells.(H) Cell survival image was taken in RD cells.(I and J) Pim1 was silenced in EV-A71-infected (J) RD and (I) HeLa cells.(K) The quantification results of (I).(L) The quantification results of (J). Protein levels of viral VP1 protein were detected and quantitated. The density of VP1 to β-actin was set as 1, and the relative fold change is indicated.Data are represented as mean ± SD (n = 3). Student\'s t test, \*p \< 0.05, compared with mock group; \*\*p \< 0.01, compared with mock group.

Inhibition of EV-A71 Replication by Knockdown of Pim1 {#sec2.2}
-----------------------------------------------------

To determine whether Pim1 was required during EV-A71 infection, an RNAi approach was employed to knockdown the level of Pim1; 48 h after small interfering RNA (siRNA) transfection, the level of Pim1 mRNA was reduced in RD and HeLa cells by 80% and 70% by siPim1-1- and siPim1-2-specific siRNAs, respectively, when compared with non-targeting sequences, as quantified by qRT-PCR (p \< 0.01) ([Figures 1](#fig1){ref-type="fig"}B and 1D). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays were performed to determine cell viability upon Pim1 silencing. There was no significant difference in cell number between siPim1-transfected cells and non-target RNA-transfected cells at 24 and 48 h post transfection (data not shown).

RD or HeLa cells were transfected with siPim1-1- or siPim1-2-specific siRNA at 40 nM or non-target siRNA as control. After 24-h transfection, cells were infected with EV-A71 at an MOI of 0.01. As shown in [Figures 1](#fig1){ref-type="fig"}C and 1E, extracellular virion RNA levels were strongly decreased in Pim1-specific siRNA-treated cells when compared with cells treated with non-targeting sequences (p \< 0.01). The viral titer was also determined after silencing Pim1. The results showed that the viral titer was significantly decreased in both RD and HeLa cells after knockdown of Pim1 ([Figures 1](#fig1){ref-type="fig"}F and 1G). Knockdown of Pim1 protected the cytopathic effects induced from EV-A71 infection in RD cells ([Figure 1](#fig1){ref-type="fig"}H). The viral protein (VP1) expression level was determined in both RD and HeLa cells. Results showed that VP1 was significantly decreased in both RD and HeLa cells after silencing Pim1 ([Figures 1](#fig1){ref-type="fig"}I--1L).

Promoting EV-A71 Replication by Ectopic Expression of Pim1 {#sec2.3}
----------------------------------------------------------

To further validate the function of Pim1 on virus replication, we conducted gain-of-function studies by ectopic expression of Pim1 by transfection of a Pim1-expressing plasmid into both RD and HeLa cells. We showed that ectopic expression of Pim1 increased viral titers both in RD and HeLa cells ([Figures 2](#fig2){ref-type="fig"}A and 2B). The viral VP1 protein level also significantly increased in the cells with ectopic expression of Pim1 ([Figures 2](#fig2){ref-type="fig"}C--2F). Furthermore, we performed a rescue experiment to show the function of Pim1 in EV-A71 infection. We first knocked down the endogenous Pim1 expression by an siRNA that specifically targets the 3′ UTR in RD cells, ectopically expressed Pim1 (resistance to siRNA) with a plasmid for 48 h, and then infected with EV-A71 at MOI = 1 for 24 h. Our results showed that the reduced VP1 level by Pim1 depletion was restored by the ectopic Pim1 expression, excluding the possibility that the VP1 decrease by siRNA is due to off-target effects ([Figures 2](#fig2){ref-type="fig"}G and 2H).Figure 2Promoting EV-A71 Replication by Ectopic Expression of Pim1(A and B) After ectopic expression of Pim1, viral titer was determined following the below-mentioned methods in (A) RD and (B) HeLa cells.(C and E) Pim1 was ectopically expressed in EV-A71-infected cells at MOI 1 for 24 h in (C) RD and (E) HeLa cells. Protein levels of Pim1 and viral protein VP1 were detected. β-Actin was used as the internal control.(D) The quantification results of (C).(F) The quantification results of (E).(G) siRNA targeting Pim1 3′ UTR at 40 nM was co-transfected with the Pim1 expression plasmid for 48 h in RD cells and then infected with EV71 at MOI 1 for 24 h.(H) The quantification results of (G). The cell lysates were collected for western blot assay. Protein levels were detected and quantitated. The density of individual protein to β-actin in the control was set as 1, and the relative fold change is indicated.Data are represented as mean ± SD (n = 3). \*p \< 0.05, compared with mock group; \*\*p \< 0.01, compared with mock group.

Enhancing Viral IRES Activity by Pim1 {#sec2.4}
-------------------------------------

It is well known that enterovirus protein translation is initiated through viral IRES elements in a cap-independent manner. A dicistronic reporter plasmid was used to evaluate EV-A71 IRES activity when Pim1 was modulated ([Figure 3](#fig3){ref-type="fig"}A). The relative IRES activity is represented by calculating the ratio of FLuc expression to RLuc expression. As indicated in the [Methods](#sec4){ref-type="sec"} section, Pim1 was over-expressed or silenced by transfecting with a Pim1-expressing plasmid or siRNA for 24 h and then transfected with pIRES plasmid. The IRES activity was analyzed 48 h after first round transfection. As shown in [Figures 3](#fig3){ref-type="fig"}B and 3C, over-expression of Pim1 increased the EV-A71 IRES activity to 200% of the control, whereas knockdown of endogenous Pim1 expression decreases EV-A71 IRES activity to 40% of the control. We later co-transfected pIRES and a viral protein-expressing plasmid individually. Our results showed that viral 2A^pro^ was the most effective protein that increased the IRES activity ([Figure 3](#fig3){ref-type="fig"}D). After we transfected all viral protein expression plasmids into 293T cells, we found that viral 2A^pro^ as well as VP4, 2B, and 3B stimulated Pim1 expression, whereas only 2A^pro^ significantly increased the mRNA level of Pim1 by more than two times ([Figure 3](#fig3){ref-type="fig"}E). To further address our findings, we then performed the rescue experiments. We silenced Pim1 and then ectopically expressed 2A^pro^. We demonstrated that 2A^pro^ rescued the reduction of IRES activity after knockdown of Pim1 ([Figure 3](#fig3){ref-type="fig"}F).Figure 3Enhancing Viral IRES Activity by Pim1(A) A diagram of the dicistronic reporter plasmid, which was used to evaluate EV-A71 IRES activity when Pim1 was modulated.(B and C) (B) The relative IRES activity after ectopic expression of Pim1 or (C) knockdown of Pim1 in 293T cells.(D) After co-transfection of the reporter plasmid and individual viral protein expression plasmid into 293T cells for 48 h, the RLuc and FLuc activities were analyzed.(E) The relative mRNA level of Pim1 was determined by qRT-PCR assay after transfection of the individual viral protein expression plasmid into 293T cells for 48 h.(F) IRES activities after ectopic expression of 2A^pro^, with or without silencing of Pim1. Results are represented as mean ± SD from three independent experiments. \*p \< 0.05, \*\*p \< 0.01.

Suppression of EV-A71 Infection by Pim1 Inhibitors {#sec2.5}
--------------------------------------------------

Highly selective Pim1 inhibitors have been developed for anti-tumor activity in the past decade. CX-6258 ((3E)-5-chloro-3-\[\[5-\[3-\[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)carbonyl\]phenyl\]-2-furanyl\]methylene\]-1,3-dihydro-2H-indol-2-one), SGI-1776 (N-\[(1-methyl-4-piperidinyl)methyl\]-3-\[3-(trifluoromethoxy)phenyl\]-imidazo\[1,2-b\]pyridazin-6-amine), and AZD-1208 ((5Z)-\[\[2-\[(3R)-3-amino-1-piperidinyl\]\[1,1′-biphenyl\]-3-yl\]methylene\]-2,4-thiazolidinedione) are novel, orally bioavailable inhibitors for treating patients with cancer in clinical trials ([@bib9], [@bib2], [@bib11]). To further test whether Pim1 could be a potential drug target against EV-A71 infection, we examined the effects of these inhibitors on EV-A71 infection in both RD and HeLa cells. We first tested all the inhibitors on cell viability in 293T, RD, and HeLa cells by MTT assay. Our results showed that SGI-1776 and CX-6258 inhibited cell growth at a higher concentration, whereas AZD-1208 did not affect cell growth ([Figure S1](#mmc1){ref-type="supplementary-material"}). We pretreated RD or HeLa cells for 2 h with indicated inhibitors and concentrations and then infected with EV-A71 for 24 h at MOI 1. As shown in [Figures 4](#fig4){ref-type="fig"}A--4L, the VP1 expression level was remarkably repressed by Pim1 inhibitors in a dose-dependent manner. CX-6258 showed the best inhibitory effects in RD cells ([Figures 4](#fig4){ref-type="fig"}A and 4G). We further used CX-6258 as a Pim1 inhibitor to determine the extracellular viral mRNA levels, as mentioned above. The results showed that after inhibiting Pim1, viral mRNA levels were significantly decreased both in RD and HeLa cells ([Figures 4](#fig4){ref-type="fig"}M and 4N). In addition, the viral titer was also decreased by more than 10^3^ after inhibiting Pim1 activity with CX-6258 in RD and HeLa cells ([Figures 4](#fig4){ref-type="fig"}O and 4P).Figure 4Suppressing EV-A71 Infection by Pim1 Inhibitors(A--F) Different Pim1 inhibitors CX-6258 (A and D), AZD-1208 (B and E), and SGI-1776 (C and F) were added in the culture media at the indicated concentration for 2 h with 10% fetal bovine serum and then cells were infected with EV-A71 at MOI 1 for 24 h; 0.5% DMSO was loaded in the control group. The VP1 protein level was determined, and beta-actin was loaded as internal control.(G and J) The quantification results of (A) and (D), respectively.(H and K) The quantification results of (B) and (E), respectively.(I and L) The quantification results of (C) and (F), respectively.(M and N) RD and HeLa Cells were firstly treated with CX-6258 at the indicated concentrations for 2 h, then infected with EV-A71 at MOI 0.01 for 72 h. The extracellular viral RNA levels in the supernatant were determined by qRT-PCR.(O and P) RD and HeLa Cells were firstly treated with CX-6258 at the indicated concentration for 2 h, then infected EV-A71 at MOI 0.01 for 72 h. The viral titer in the supernatant was measured by TCID50 assay. Protein levels were detected and quantitated by image density. The density of individual protein to β-actin in the control was set as 1, and the relative fold change is indicated.Results are represented as mean ± SD from three independent experiments. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Inhibition of 2A^pro^-Mediated eIF4G Cleavage by Inhibition of Pim1 {#sec2.6}
-------------------------------------------------------------------

To address how Pim1 affects the IRES activity regulated by 2A^pro^, we checked the effect of Pim1 on 2A^pro^ cleavage activity. We and others previously reported that the IRES-driven translation was activated after the cleavage of eIF4G by 2A^pro^ ([@bib20], [@bib5], [@bib3]). We first tested whether Pim1 inhibitors could affect the cleavage of eIF4G after virus infection. As shown in [Figures 5](#fig5){ref-type="fig"}A and 5B, RD cells were treated with CX-6258 at different concentrations and then infected with EV-A71 at MOI 10. After 9 h p.i., the cleavage of eIF4G was significantly inhibited. We confirmed the expression plasmid 2A^pro^ cleavage activity in 293T cells ([Figures 5](#fig5){ref-type="fig"}C and 5E). To further demonstrate the underlying mechanism, HEK293T cells were first treated with CX-6258 for 2 h and then co-transfected with a 2A^pro^-expressing plasmid for 36 h. We found that the cleavage of eIF4G was also inhibited with Pim1 inhibitor in a dose-dependent manner ([Figures 5](#fig5){ref-type="fig"}G and 5H). Similarly, when 293T cells were transfected with the Pim1 expression plasmid for 48 h, and then infected with EV-A71 at MOI 10 for the indicated time points, the cleavage of eIF4G was upregulated in the Pim1 ectopically expressed cells ([Figures 5](#fig5){ref-type="fig"}D and 5F). To test whether the Pim1 inhibitor would directly affect 2A^pro^ activity, we further examined the status of 2A^pro^ -mediated eIF4G cleavage in Pim1 knockdown cells treated with CX-6258 at different concentrations (1, 2, and 4 μM). Our results showed that CX-6258 did not further affect 2A^pro^ activity in the Pim1-depleted cells ([Figures 5](#fig5){ref-type="fig"}I and 5J), demonstrating that the inhibitory effects of 2A^pro^-mediated eIF4G cleavage were mediated through the suppressed Pim1 kinase activity.Figure 5Inhibiting 2A^pro^-mediated eIF4G Cleavage by CX-6258(A) RD cells were treated with different concentrations of CX-6258 and then infected with EV-A71 at MOI 10. After culture for 9 h, cell lysates were collected and the cleavage of eIF4G was determined.(B) The quantification results of (A).(C) HEK293T cells were transfected with p2A^pro^ (0.1, 0.5, and 1 μg) for 36 h, and the cleavage of eIF4G was determined.(D) HEK293T cells were first treated with different concentrations of CX-6258 for 2 h and transfected with 1 μg 2A^pro^-expressing plasmid for 36 h. The cleavage of eIF4G was determined.(E and F) The quantification results of (C) and (D), respectively.(G) 293T cells were transfected with a Pim1-expressing plasmid for 48 h and then infected with EV-A71 at MOI 10 for the indicated time. The cleavage of eIF4G was determined.(H) The quantification results of (G).(I) 293T cells were first transfected with Pim1-specific siRNA for 48 h and then treated with CX-6258 at the indicated concentrations for 2 h, followed by transfection of a 2A^pro^-expressing plasmid at 48 h. Cell lysates were collected, and the status of eIF4G cleavage was examined.(J) The quantification results of (I). Protein levels were detected and quantitated by image density. The density of individual protein to β-actin or GAPDH in the control was set as 1, and the relative fold change is indicated.Results are represented as mean ± SD from three independent experiments. \*p \< 0.05, \*\*p \< 0.01.

Induction of the Cytoplasmic Accumulation of AUF1 by Inhibition of Pim1 {#sec2.7}
-----------------------------------------------------------------------

We further explored whether other mechanism(s) of Pim1 are involved in the regulation of the viral IRES activity. After treating cells with the Pim1 inhibitor CX-6258 for 2 h without viral infection or 2A expression, we isolated the cytoplasm and nuclear proteins and applied western blot assays. After examining the translocation of ITAF factors, including AUF1, hnRNP K, FBP1, and Sam68, we found that only AUF1, a suppressor of the IRES, was affected by the Pim1 inhibitor. The accumulation of AUF1 in the cytoplasm was significantly increased ([Figures 6](#fig6){ref-type="fig"}A and 6B). Consistently, only AUF1, but not hnRNP K, FBP1, or Sam68, translocated from the nucleus to the cytosol after knockdown of Pim1 by target-specific siRNA ([Figures 6](#fig6){ref-type="fig"}C and 6D). We also used confocal images to examine the cellular localization of AUF1. AUF1 accumulation was shown in the cytoplasm in the cells treated with the Pim1 inhibitor ([Figure 6](#fig6){ref-type="fig"}E). We also noticed that AUF1 appeared to form puncta in the cytoplasm at 2 and 4 μM concentrations of CX-6258, which correlated with the stress response of Pim1 and AUF1 ([@bib1], [@bib27]).Figure 6Inducing AUF1 Cytoplasmic Accumulation by CX-6258(A) RD cells were treated with CX-6258 at the indicated concentrations for 2 h, and then the cytoplasmic and nuclear proteins were extracted. The cytoplasm and nuclear distribution of AUF1, Sam68, hnRNP K and FUBP1 were determined by western blot assay.(B) The quantification results of (A).(C) Pim1-specific siRNAs were transfected into RD cells for 48 h. The cytoplasmic and nuclear proteins were extracted. The protein levels of AUF1, Sam68, hnRNP K, and FUBP1 were examined by western blot assays.(D) The quantification results of (C).(E) The cytoplasmic and nuclear distribution of AUF1 was detected in RD cells after treating with CX-6258 at indicated concentrations for 2 h under a fluorescence microscope. The yellow arrows indicated the representative cells of AUF1 translocated in the cytosole.Results are represented as mean ± SD from three independent experiments. \*p \< 0.05, \*\*p \< 0.01.

Discussion {#sec3}
==========

In this study, we have provided evidence that Pim1 is a positive regulator for EV-A71 replication. Pim1 elevated EV-A71 replication by upregulating IRES activity by increasing 2A^pro^-mediated eIF4G cleavage and blocking AUF1 translocation from the nucleus to the cytosol. More importantly, we discovered that Pim1 inhibitors potently repressed EV-A71 infection. Particularly, CX-6258 reduced the viral titer over 1,000 times, a strong indication as a potential antiviral drug against enterovirus infections.

Previously, different expression patterns were observed, and many novel host genes regulated by EV-A71 infection have been identified, including those involved in the immune response, endoplasmic reticulum stress, and vesicular trafficking. In 2004, Shih et al. observed the upregulation of apoptotic genes in response to EV-A71 infection by analyzing 10,692 gene profiles in infected human SF268 cells ([@bib30]). In addition, Leong et al. found that there is a trend to inhibit cell apoptosis and cell growth arrest by analyzing 7,600 genes in EV-A71 (strain MS/7423/87, B2 sub-genotype)-infected RD cells ([@bib15]). In 2011, Kan et al. used RNAi screening and identified 256 host factors involved in EV-A71 replication in RD cells ([@bib37]). However, the function and importance of these host factors in EV-A71 replication are largely unclear. In our previous studies, we demonstrated that several heat shock proteins, including ERp57, Hsc70, and Hsp27, play a crucial role in EV-A71 infection by regulating viral IRES activities. In these studies, we showed that heat shock protein inhibitors markedly suppressed virus replication by decreasing IRES activities ([@bib36], [@bib5], [@bib3]).

It was particularly interesting to find that Pim1, an important kinase involved in human cancers and never reported to be involved in the process of EV-A71 infection, was upregulated following EV-A71 infection ([Figure 1](#fig1){ref-type="fig"}A). We postulated that Pim1 must have played important role in EV-A71 replication because the process of virus replication often shares similar signaling cascades to those involved in cancer cell growth, migration, or cell death. By loss- and gain-of-function studies, we showed that Pim1 played crucial role in facilitating EV-A71 replication ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Our data demonstrated the importance of Pim1 in EV-A71 infection.

IRES plays a key role in the synthesis of viral proteins during EV-A71 infection ([@bib7]). In this study, we further demonstrated that Pim1 promoted IRES activity upon EV-A71 infection ([Figure 3](#fig3){ref-type="fig"}). EV-A71 infection increased Pim1 expression level ([Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}), and the increased Pim1 expression promoted EV-A71 replication ([Figure 2](#fig2){ref-type="fig"}). We then tested if Pim1 inhibitors restricted EV-A71 replication. All three Pim1-specific inhibitors (SGI-1776, CX-6258, AZD-1208) showed a high potency to suppress viral infectivity ([Figure 4](#fig4){ref-type="fig"}). We chose the best antiviral inhibitor CX-6258 and tested its effects on both intracellular and extracellular viral RNA levels, which reflected viral replication and reproduction, respectively. We showed that both viral RNA levels and viral titer dramatically decreased in a dose-dependent manner ([Figure 4](#fig4){ref-type="fig"}).

EV-A71 recruits many host factors to facilitate viral protein synthesis via IRES-mediated translation. We previously showed that Hsc70 binds the full length of viral RNA and promotes IRES activity. Hsc70 regulates IRES activity and serves as an antiviral target of EV-A71 infection ([@bib5]). It is interesting to test whether Pim1 kinase could enhance IRES activity in other ways. We first found that 2A^pro^ rescued the reduced IRES activity in Pim1-silenced cells. 2A^pro^ is one of the well-known proteases that cleaves eIF4G to promote viral replication ([@bib8]). The cleaved eIF4G separates into two parts, and the C-terminal part directly binds IRES to initiate the viral translation process ([@bib25]). However, it was not known if Pim1 could affect IRES activity by regulating 2A^pro^ activity. Surprisingly, we did observe that inhibition of Pim1 by either both siRNAs or the inhibitor (CX-6258) inhibited the cleavage of eIF4G cleavage upon EV-A71 infection ([Figure 5](#fig5){ref-type="fig"}). The Pim1 inhibitor suppressed 2A^pro^-mediated eIF4G cleavage in a dose-dependent manner ([Figure 5](#fig5){ref-type="fig"}). More importantly, the Pim1 inhibitor showed no effect on 2A^pro^-mediated eIF4G cleavage after knockdown of Pim1, demonstrating the high specificity of the inhibitor to Pim1 kinase, instead of a possible effect on 2A protease. In addition, we revealed that Pim1 (possibly the dominant p40 isoform) played a crucial role in the control of AUF1 cytosol translocation ([Figure 6](#fig6){ref-type="fig"}).

In conclusion, we have demonstrated that Pim1 contributes to EV-A71 infection through two distinct mechanisms. Pim1 exhibits a positive role in EV-A71 infection by enhancing IRES activity by stimulating 2A^pro^-mediated eIF4G cleavage and blocking AUF1 cytosol translocation ([Figure 7](#fig7){ref-type="fig"}). Most importantly, we provide evidence that Pim1 inhibitors, particularly CX-6258, decrease viral reproduction by over 1,000 times, providing a potent antiviral agent for potential clinical settings in the future.Figure 7Diagram of Pim1 Function in EV-A71 Infection

Limitations of the Study {#sec3.1}
------------------------

Our study has demonstrated that Pim1 exhibits a positive role in EV-A71 replication by enhancing IRES activity by two distinct mechanisms, i.e., enhancing 2A^pro^-mediated eIF4G cleavage and blocking AUF1 cytosol translocation. We have performed several experiments such as western blot, qRT-PCR, and mass spectrum analysis to see if there are interaction sites between these proteins. However, we failed to determine whether Pim1 directly binds eIF4G or affects eIF4G phosphorylation. The interplay between VP4, 2B, 3B, and Pim1 cannot be excluded, and further studies are required in the future. Nevertheless, as anticancer agents, Pim1 inhibitors show great antiviral activities that are very attractive for the treatment of patients with HFMD in the future.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods and Figure S1

The work was partially supported by grants from National Science Foundation of China \[81671995\], grants from The Science Technology and Innovation Committee of Shenzhen Municipality \[JCYJ20170818100531426, JCYC20180507181627057\], the General Research grant of Hong Kong \[11100215\], and Strategic funds from City University of Hong Kong.

Author Contributions {#sec6}
====================

F.Z., J.L., Q.W., and Y.C. performed the experiments; M.-L.H. designed and supervised the research; and F.Z. and M.-L.H. analyzed data and wrote the manuscript.

Declaration of Interests {#sec7}
========================

The authors declare no competing financial interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.isci.2019.08.008>.

[^1]: These authors contributed equally

[^2]: Lead Contact
